Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Andries

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1992
Improved endothelial viability of heart valves cryopreserved by a new techniqueX J Feng, C E van Hove, R Mohan, et al.
Muscle & Nerve|July 9, 2019
Development of grading scales of pedal sensory loss using Mokken scale analysis on the Rotterdam Diabetic Foot Study Test Battery dataWillem D Rinkel, M Hosein Aziz, Johan W Van Neck, et al.
British Journal of Pharmacology|February 4, 2012
The cholecystokinin CCK2 receptor antagonist, JNJ-26070109, inhibits gastric acid secretion and prevents omeprazole-induced acid rebound in the ratT D Barrett, G Lagaud, P Wagaman, et al.
Circulation|September 24, 1999
Improvement of endocardial and vascular endothelial function on myocardial performance by captopril treatment in postinfarct rat heartsX L Qi, D J Stewart, H Gosselin, et al.
British Journal of Cancer|November 15, 2007
R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignanciesJ Arts, P Angibaud, A Mariën, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinomaS Temam, J Spicer, F Farzaneh, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1992
Improved endothelial viability of heart valves cryopreserved by a new techniqueX J Feng, C E van Hove, R Mohan, et al.
Muscle & Nerve|July 9, 2019
Development of grading scales of pedal sensory loss using Mokken scale analysis on the Rotterdam Diabetic Foot Study Test Battery dataWillem D Rinkel, M Hosein Aziz, Johan W Van Neck, et al.
British Journal of Pharmacology|February 4, 2012
The cholecystokinin CCK2 receptor antagonist, JNJ-26070109, inhibits gastric acid secretion and prevents omeprazole-induced acid rebound in the ratT D Barrett, G Lagaud, P Wagaman, et al.
Circulation|September 24, 1999
Improvement of endocardial and vascular endothelial function on myocardial performance by captopril treatment in postinfarct rat heartsX L Qi, D J Stewart, H Gosselin, et al.
British Journal of Cancer|November 15, 2007
R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignanciesJ Arts, P Angibaud, A Mariën, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinomaS Temam, J Spicer, F Farzaneh, et al.
Pageof 8